# RISPERDAL CONSTA
> **NDA021346** · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2003-10-29
## Drug
- **FDA Application Number:** NDA021346
- **Application type:** New Drug Application
- **Brand name:** RISPERDAL CONSTA
- **Generic name:** RISPERIDONE
- **Active ingredients:** RISPERIDONE
- **Dosage form:** POWDER
- **Route:** INTRAMUSCULAR
- **Marketing status:** Prescription
- **Sponsor:** JANSSEN PHARMS
- **Manufacturer:** Janssen Pharmaceuticals, Inc.
- **First approval:** 2003-10-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021346)
---
*AI Analytics · CC0 1.0*